US IDE Study of the Contour NEurovasCular System™ for IntraCranial Aneurysm Repair
Public ClinicalTrials.gov record NCT04852783. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of this trial is to gather data on the safety and effectiveness of the Contour /Contour 021 System in the treatment of wide-necked bifurcated saccular, intracranial aneurysms for submission to FDA in support of a premarket approval application for the device.
Study identification
- NCT ID
- NCT04852783
- Recruitment status
- Active, not recruiting
- Study type
- Interventional
- Phase
- Phase 4
- Enrollment
- 250 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years to 75 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Aug 5, 2021
- Primary completion
- Feb 19, 2026
- Completion
- Jan 31, 2030
- Last update posted
- Mar 30, 2026
2021 – 2030
United States locations
- U.S. sites
- 20
- U.S. states
- 12
- U.S. cities
- 19
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Swedish Medical Center | Englewood | Colorado | 80113 | — |
| Baptist Health | Jacksonville | Florida | 32207 | — |
| University of Chicago | Chicago | Illinois | 60637 | — |
| Advocate Aurora Health | Park Ridge | Illinois | 60068 | — |
| University of Kansas Medical Center | Kansas City | Kansas | 66160 | — |
| Massachusetts General Hospital | Boston | Massachusetts | 02114 | — |
| UMASS Medical Center | Worcester | Massachusetts | 01655 | — |
| University at Buffalo Neurosurgery | Buffalo | New York | 14203 | — |
| NYU Langone Health | New York | New York | 10016 | — |
| Stony Brook Medicine | Stony Brook | New York | 11794 | — |
| Montefiore Medical Center | The Bronx | New York | 10467 | — |
| Westchester Medical Center | Valhalla | New York | 10595 | — |
| NC Heart and Vascular Research LLC | Raleigh | North Carolina | 27607 | — |
| The Hospital of the University of Pennsylvania | Philadelphia | Pennsylvania | 19104 | — |
| Thomas Jefferson University | Philadelphia | Pennsylvania | 19107 | — |
| University of Pittsburgh Medical Center | Pittsburgh | Pennsylvania | 15213 | — |
| Alejandro Spiotta | Charelston | South Carolina | 29425 | — |
| Semmes-Murphy Clinic | Memphis | Tennessee | 38120 | — |
| Medical City Plano | Plano | Texas | 75075 | — |
| Swedish Neuroscience Institute | Seattle | Washington | 98122 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT04852783, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Mar 30, 2026 · Synced Sep 6, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT04852783 live on ClinicalTrials.gov.